| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Context Therapeutics Inc. | Former Section 16 officer | Stock Option (right to buy) | 29,223 | 15 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc. | 15 Feb 2022 | 1 | $0 | 4 | Former Section 16 officer | 17 Feb 2022, 15:56 |
| CNTX | Context Therapeutics Inc. | 22 Oct 2021 | 2 | $0 | 4/A | SVP of R&D | 17 Dec 2021, 15:12 |
| CNTX | Context Therapeutics Inc. | 22 Oct 2021 | 2 | $0 | 4 | SVP of R&D | 25 Oct 2021, 17:29 |
| CNTX | Context Therapeutics Inc. | 19 Oct 2021 | 0 | $0 | 3/A | SVP of R&D | 17 Dec 2021, 15:10 |